CrushSCI.com
Journal Selection & Manuscript Polishing Services
JACC-Heart Failure journal cover Medicine
Back to journal directory

Review Cycle Records

JACC-Heart Failure

Elsevier SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
148.8Average days
144Median days
54Fastest days
349Longest days
3922025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

196 days

The MagMa Study

AuthorsPhillip Suwalski; Finn Wilke; Ekaterina Latinova; Gabriele Paci; Gamze Satilmis; Karin Klingel; Sebastian Kelle; January Weiner; Dieter Beule; Thomas F. Lüscher; Ulf Landmesser; Bettina Heidecker

AffiliationsGerman Heart Center of Charité, Charité–University Medicine Berlin, Berlin, Germany; Department of Cardiopathology, Institute for Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany; Berlin Institute of Health, Charité–University Medicine Berlin, Berlin, Germany; Heart Division, Royal Brompton Hospital, King’s College and Imperial College London, London, United Kingdom; Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland; German Center for Cardiovascular Research, Berlin, Germany

Source PDF DOI Publisher page
77 days

NOTIFY-HF

AuthorsJoseph Assad; Nancy E. Briggs; Sidney Lo; Rohan Rajaratnam; Giuseppe Femia; Dominic Leung; Hany Dimitri

AffiliationsDepartment of Cardiology, Liverpool Hospital, South Western Sydney Local Health District, Sydney, New South Wales, Australia; South West Clinical School, School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia; Ingham Institute of Applied Medical Research, Liverpool, New South Wales, Australia; Mark Wainwright Analytical Centre, University of New South Wales, Sydney, New South Wales, Australia; Western Sydney University, School of Medicine, Sydney, New South Wales, Australia; The University of Sydney, School of Medicine, Camperdown, New South Wales, Australia

Source PDF DOI Publisher page
192 days

Implantable Cardioverter-Defibrillator Therapy in Contemporary Heart Failure Patients

AuthorsMehmet K. Aktaş; Khawaja M. Talha; Ilan Goldenberg; Wojciech Zareba; Michael Böhm; Amr Abdin; Martina Brueckmann; Cordula Zeller; Liliana Zaremba-Pechmann; Stuart Pocock; Faiez Zannad; Stefan D. Anker; Gerasimos Filippatos; Javed Butler; João Pedro Ferreira; Milton Packer

AffiliationsClinical Cardiovascular Research Center, University of Rochester, Rochester, New York, USA; Department of Cardiovascular Disease, Loyola University Medical Center, Maywood, Illinois, USA; Departments of Internal Medicine and Cardiology, Angiology and Intensive Care Medicine, Saarland University, Saarbrücken, Germany; Boehringer Ingelheim International GmbH, Ingelheim, Germany; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany; Elderbrook Solutions, Krakow, Poland; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom; Centre d’Investigations Cliniques Plurithématique 1433, Université de Lorraine, Institut National de la Santé et de la Recherche Médicale 1116, Centre Hospitalier Régional Universitaire de Nancy, French Clinical Research Infrastructure Network, Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, Nancy, France; Department of Cardiology (CVK) of German Heart Center Charité, German Centre for Cardiovascular Research (DZHK), Charité Universitätsmedizin, Berlin, Germany; National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, Greece; Department of Medicine, University of Mississippi, Jackson, Mississippi, USA; Baylor Scott and White Research Institute, Dallas, Texas, USA; Cardiovascular R&D Center, Faculty of Medicine, University of Porto, Porto, Portugal; Heart Failure Clinic, Internal Medicine Department, Hospital de Gaia/Espinho, Gaia, Portugal; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA

Source PDF DOI Publisher page
64 days

Endomyocardial Biopsy-Based Inflammatory Phenotypes Predict Outcomes in Virus-Negative Dilated and Inflammatory Cardiomyopathy

AuthorsChristian Baumeier; Felicitas Escher; Ganna Aleshcheva; Gordon Wiegleb; Dominik Harms; C. Thomas Bock; Alexander Krannich; Heinz-Peter Schultheiss

AffiliationsInstitute for Cardiac Diagnostics and Therapy (IKDT), Berlin, Germany; Deutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Campus Virchow Klinikum, Berlin, Germany; DZHK (German Center for Cardiovascular Research), partner side Berlin, Germany; Robert Koch Institute (RKI), Department Infectious Diseases, Berlin, Germany; BioStats GmbH, Berlin, Germany

Source PDF DOI Publisher page
85 days

Reappraising Left Ventricular Wall Thickness in Developing Clinical Suspicion for Transthyretin Cardiac Amyloidosis

AuthorsHarsh Patolia; Michel Chedid El Helou; Alexandra Manaila; Faysal Massad; Ziad Zalaquett; Arianne Agdamag; J. Emanuel Finet; Andres Carmona Rubio; Deborah Kwon; Wael Jaber; Patrick Collier; Mazen Hanna; Trejeeve Martyn

AffiliationsCleveland Clinic, Heart, Vascular & Thoracic Institute, Department of Cardiovascular Medicine, Cleveland, Ohio, USA; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA; Amyloidosis Center, Cleveland Clinic, Cleveland Ohio, USA

Source PDF DOI Publisher page
108 days

Forty Years of Heart Failure Drug Clinical Trials

AuthorsAndrea D. Rivera; Mitchell A. Psotka; Mona Fiuzat; Christopher M. O’Connor

AffiliationsInova Schar Heart and Vascular, Falls Church, Virginia, USA; School of Medicine, Duke University, Durham, North Carolina, USA

Source PDF DOI Publisher page
180 days

Impact of Donor Left Ventricular Geometric Remodeling and Hypertrophy on Heart Acceptance and Recipient Survival

AuthorsChristian O’Donnell; Juka S. Kim; Akansha Tarun; Bettia E. Celestin; Alexander K. Karius; Shadi P. Bagherzadeh; Tyler A. Intrieri; Natalie Tapaskar; Shiqi Zhang; Yingjie Weng; Jonathan Zaroff; Louise Y. Sun; Brian Wayda; Francois Haddad; Kiran K. Khush

AffiliationsDivision of Cardiothoracic Anesthesiology, Stanford University School of Medicine, Stanford, California, USA; Department of Medicine, Stanford University School of Medicine, Stanford, California, USA; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA; Division of Cardiology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Division of Cardiology, University of Texas Southwestern, Dallas, Texas, USA; Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, California, USA; Division of Cardiovascular Medicine, Kaiser Permanente San Francisco Medical Center, San Francisco, California, USA; Division of Cardiology, New York University School of Medicine, New York, New York, USA; Stanford Cardiovascular Institute, Stanford, California, USA

Source PDF DOI Publisher page
183 days

Insurance Type Is Associated With Management and Outcomes in Young Adults Hospitalized With Heart Failure

AuthorsWacim Benyoucef; Vi-Anh Hoang; R.J. Waken; Karen E. Joynt Maddox; Erin D. Solomon; Gmerice Hammond

AffiliationsSchool of Medicine, University of Missouri, Columbia, Missouri, USA; Division of General Medicine and Geriatrics, School of Medicine, Washington University, St Louis, Missouri, USA; Division of Cardiology, School of Medicine, Washington University, St. Louis, Missouri, USA; Institute of Informatics, Data Science, and Biostatistics, School of Medicine, Washington University, St. Louis, Missouri, USA; Center for Advancing Health Services, Policy and Economics Research, School of Medicine, Washington University, St. Louis, Missouri, USA; Institute of Clinical and Translational Sciences, School of Medicine, Washington University, St. Louis, Missouri, USA

Source PDF DOI Publisher page
349 days

Geographic Variation in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

AuthorsTracy T. Makuvire; Carolyn S.P. Lam; Maria A. Pabon; Brian L. Claggett; Ian J. Kulac; Akshay S. Desai; Pardeep S. Jhund; Alasdair D. Henderson; Flaviana Amarante; Min Chen; Satoshi Yamashita; Katharina Mueller; Toru Kondo; Naoki Sato; Chang-sheng Ma; Michele Senni; Sanjiv J. Shah; Adriaan A. Voors; Faiez Zannad; Bertram Pitt; John J.V. McMurray; Scott D. Solomon; Muthiah Vaduganathan

AffiliationsCardiovascular Division, Brigham and Women’s Hospital, and Harvard Medical School, Boston, Massachusetts, USA; National Heart Centre Singapore and Duke-National University of Singapore, Singapore, Singapore; British Heart Foundation Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom; Cardiology and Nephrology Clinical Development, Bayer SA, São Paulo, Brazil; ICON Strategic Solutions, ICON Clinical Research Germany GmbH, Langen, Germany; Bayer Yakuhin, Ltd, Medical Affairs and Pharmacovigilance, Osaka, Japan; Bayer AG, Research and Development, Pharmaceuticals, Wuppertal, Germany; Kawaguchi Cardiovascular and Respiratory Hospital, Kawaguchi, Japan; Cardiology Department, Beijing Anzhen Hospital Affiliated with Capital Medical University, Beijing, People's Republic of China; University of Milano-Bicocca and Papa Giovanni XXIII Hospital, Bergamo, Italy; Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA; University Medical Center Groningen, Groningen, the Netherlands; Université de Lorraine, INSERM Clinical Investigation Centre, Centre Hospitalier Universitaire, Nancy, France; School of Medicine, University of Michigan, Ann Arbor, Michigan, USA

Source PDF DOI Publisher page
54 days

Psychiatric Disorders and Mortality in Heart Failure

AuthorsXingbo Mo; Hua Chen; Imre Janszky; Ulf Dahlström; Jette Möller; Yajun Liang; Krisztina D. László

AffiliationsDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Medical College of Soochow University, Suzhou, China; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden; Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway; Department of Cardiology, Linköping University, Linköping, Sweden; Department of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.